Acs: 180 and Advia Centaur Anti-Thyroglobulin Immunoassays
by Bayer Corp.
510(k) K012777
Active
510(k)
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK012777 | Date22 Oct 2001 | StatusActive |
Recalls
-
- Terminated Z-1236-2019
- Terminated Z-1235-2019
- Terminated Z-1233-2019
- Terminated Z-1234-2019
Positive bias anti-thyroglobulin with ADVIA Centaur aTG kit lots ending in 316 and lower and Atellica IM aTG kit lots ending in 317 and lower when compared to the standardization to World Health Organization (WHO) Reference Preparation MRC 65/93 stated in the Instructions for Use (IFU).
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JZO
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5870
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent